Well-differentiated papillary mesothelioma: Clustering in a Portuguese family with a germline BAP1 mutation

Annals of Oncology

Volumn 24, Issue 8, 2013, Pages 2147-2150

  Ribeiro, C ^a   Campelos, S ^a   Moura, C S ^b,c   Machado, J C ^c,d   Justino, A ^d   Parente, B ^a  

^a CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

^c University of Porto   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

BAP1; Familiar; Mutation; Well differentiated papillary mesothelioma

Indexed keywords

ALKALINE PHOSPHATASE; CALRETININ; CISPLATIN; COMPLEMENTARY DNA; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN ANTIBODY; GAMMA GLUTAMYLTRANSFERASE; GENOMIC DNA; PEMETREXED;

ABDOMINAL PAIN; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASCITES; BAP1 GENE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; CELL PROLIFERATION; CHRONIC GASTRITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIOID CELL; FAMILIAL CANCER; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENE MUTATION; GENETIC ASSOCIATION; HEREDITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LAPAROSCOPY; MESOTHELIOMA; MULTIPLE CYCLE TREATMENT; MUTATOR GENE; NUCLEOTIDE SEQUENCE; PERITONEUM CANCER; PLEURA CANCER; PORTUGAL; PRIORITY JOURNAL; SURVIVAL TIME; UVEA MELANOMA; VISUAL ACUITY; WELL DIFFERENTIATED PAPILLARY MESOTHELIOMA;

BAP1; FAMILIAR; MUTATION; WELL-DIFFERENTIATED PAPILLARY MESOTHELIOMA;

ADULT; ASBESTOS; CLUSTER ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MELANOMA; MESOTHELIOMA; MIDDLE AGED; PERITONEAL NEOPLASMS; PLEURAL NEOPLASMS; PORTUGAL; PROGNOSIS; SIBLINGS; SURVIVAL; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; UVEAL NEOPLASMS;

EID: 84881237007     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt135     Document Type: Article

References (19)

1. Clarke JM, Helft P. Long-term survival of a woman with well differentiated papillary mesothelioma of the peritoneum: a case report and review of the literature. J Med Case Rep 2010; 4: 346.
2. Galateau-Salle F, Vignaud JM, Burke L, et al. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol 2004; 28: 534-540.
3. Butnor KJ, Sporn TA, Hammar SP, et al. Well differentiated papillary mesothelioma. Am J Surg Pathol 2001; 25: 1304-1309.
4. Hoekstra A, Riben M, Frumovitz M, et al. Well differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol 2005; 98: 161-167.
5. Shukunami K, Shin-ya H, Mitsuo K, et al. Well differentiated papillary mesothelioma involving the peritoneal and pleural cavities: successful treatment by local and systemic administration of carboplatin. Tumori 2000; 86: 419-421.
6. Hollinger P, Gaeng D. Simultaneous bilateral spontaneous pneumothorax in a patient with peritoneal and pleural papillary mesothelioma. Respiration 1997; 64: 233-235.
7. Kao S, Mahon K, Lin B, et al. Pleural well-differentiated papillary mesothelioma-a case report. J Thorac Oncol 2009; 4: 920-922.
8. Carbone M, Izzettin Baris Y, Bertino P, et al. Erionite exposure in North Dakota and in the Turkish villages with mesothelioma. Proc Natl Acad Sci USA 2011; 108(33): 13618-13623.
9. Testa JR, Cheung M, Below JE, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 2011; 43(10): 1022-1025.
10. Njauw CN, Kim I, Piris A, et al. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One 2012; 7(4): e35295.
11. Wiesner T, Fried I, Ulz P, et al. Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations. JCO 2012; 30(32): e337-e340.
12. Wiesner T, Obenauf AC, Murali R, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 2011; 43: 1018-1021.
13. Abdel-Rahman MH, Pilarski R, Cebulla J CM. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. Med Genet 2011; 48: 856e859.
14. Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010; 330: 1410-1413.
15. Houlston RS, Damato BE. Genetic predisposition to ocular melanoma. Eye 1999; 13: 43-46.
16. Bott M, Brevet M, Taylor BS, et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011; 43: 668-672.
17. den Dunner JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15(1): 7-12.
18. Daya D, McCaughey W. Well differentiated papillary mesothelioma of the peritoneum: a clinicopathologic study of 22 cases. Cancer 1990; 65: 292-296.
19. Almeida DM, Freitas DM, Nogueira JA, et al. Mesotelioma papilífero bem diferenciado do peritônio: relato de caso e revisão da literatura. J Bras Patol Med Lab 2005; 41(1); 37-41.